Cargando…

HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer’s disease in a three cohorts study

Several retrospective epidemiological studies report that utilization of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) inhibitors called statins at mid-life can reduce the risk of developing sporadic Alzheimer’s disease (AD) by as much as 70%. Conversely, administration of these inhibitors in cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leduc, Valerie, De Beaumont, Louis, Théroux, Louise, Dea, Doris, Aisen, Paul, Petersen, Ronald C., Dufour, Robert, Poirier, Judes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318698/ https://www.ncbi.nlm.nih.gov/pubmed/25023145 http://dx.doi.org/10.1038/mp.2014.81

Ejemplares similares

Function and Comorbidities of Apolipoprotein E in Alzheimer's Disease
por: Leduc, Valérie, et al.
Publicado: (2011)

Association of HMGCR polymorphism with late-onset Alzheimer's disease in Han Chinese
por: Chang, Xiao-Long, et al.
Publicado: (2016)

EEG oscillations during word processing predict MCI conversion to Alzheimer's disease
por: Mazaheri, Ali, et al.
Publicado: (2017)

Anti-HMGCR Myopathy
por: Mohassel, Payam, et al.
Publicado: (2018)

An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients
por: Aksu, Yaman, et al.
Publicado: (2011)

Hierarchical Interactions Model for Predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) Conversion
por: Li, Han, et al.
Publicado: (2014)

Could Lipoprotein Lipase Play a Role in Alzheimer's Disease?
por: Blain, Jean-Francois, et al.
Publicado: (2004)

Altered Episodic Memory in Introverted Young Adults Carrying the BDNF(Met) Allele
por: Bombardier, Andreanne, et al.
Publicado: (2016)

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
por: Ma, Shizhan, et al.
Publicado: (2019)

Anti-HMGCR antibodies in systemic sclerosis
por: Hudson, Marie, et al.
Publicado: (2016)

Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study
por: Henderson, Samuel T, et al.
Publicado: (2011)

Direction of Information Flow in Alzheimer's Disease and MCI Patients
por: Vecchio, Fabrizio, et al.
Publicado: (2011)

Motor system alterations in retired former athletes: the role of aging and concussion history
por: De Beaumont, Louis, et al.
Publicado: (2013)

Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD)
por: Wood, Paul L., et al.
Publicado: (2015)

The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)
por: Risacher, Shannon L., et al.
Publicado: (2013)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

Brain properties predict proximity to symptom onset in sporadic Alzheimer’s disease
por: Vogel, Jacob W, et al.
Publicado: (2018)

Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts
por: Cao, Lei, et al.
Publicado: (2016)

Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
por: Risacher, Shannon L, et al.
Publicado: (2009)

Key inflammatory pathway activations in the MCI stage of Alzheimer’s disease
por: Pillai, Jagan A., et al.
Publicado: (2019)

Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals
por: Chipi, Elena, et al.
Publicado: (2019)

Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer’s disease: A genetic and proteomic multi-cohort study
por: Picard, Cynthia, et al.
Publicado: (2019)

Myopathy with anti-HMGCR antibodies: Perimysium and myofiber pathology
por: Alshehri, Ali, et al.
Publicado: (2015)

Anti-HMGCR Specificity of HALIP: A Confirmatory Study
por: Baucells, Andrés, et al.
Publicado: (2020)

Selective familiarity deficits in otherwise cognitively intact aging individuals with genetic risk for Alzheimer's disease
por: Schoemaker, Dorothee, et al.
Publicado: (2015)

AD-NET: Age-adjust neural network for improved MCI to AD conversion prediction
por: Gao, Fei, et al.
Publicado: (2020)

Early MCI-to-AD Conversion Prediction Using Future Value Forecasting of Multimodal Features
por: Minhas, Sidra, et al.
Publicado: (2021)

Significant association of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) rs3846662 and sirtuin 1 (SIRT1) rs7895833 and apolipoprotein E (APOE) hypermethylation with mild cognitive impairment (MCI)
por: Zou, Ting, et al.
Publicado: (2019)

Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
por: Poil, Simon-Shlomo, et al.
Publicado: (2013)

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)
por: Bauckneht, Matteo, et al.
Publicado: (2018)

Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease
por: Munawara, Usma, et al.
Publicado: (2021)

FOOD AND SUPPLEMENT COMBINATIONS TO PREVENT OR POSTPONE AGING, MCI, AND ALZHEIMER’S DISEASE
por: Pruchnicki, Alec, et al.
Publicado: (2022)

Clinical and Radiological Features of Korean Patients With Anti-HMGCR Myopathy
por: Oh, Eun Kyoung, et al.
Publicado: (2023)

Electroacupuncture regulates hepatic cholesterol synthesis by HMGCR deubiquitination in rats
por: Jin, Shu-wen, et al.
Publicado: (2023)

Modifying the minimum criteria for diagnosing amnestic MCI to improve prediction of brain atrophy and progression to Alzheimer’s disease
por: Vuoksimaa, Eero, et al.
Publicado: (2018)

Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities
por: Parent, Maxime J., et al.
Publicado: (2017)

Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer’s Disease
por: Tuwaig, Miranda, et al.
Publicado: (2017)

Morphological Factor Estimation via High-Dimensional Reduction: Prediction of MCI Conversion to Probable AD
por: Duchesne, Simon, et al.
Publicado: (2011)

Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data
por: Ye, Jieping, et al.
Publicado: (2012)

Predicting Conversion from MCI to AD Combining Multi-Modality Data and Based on Molecular Subtype
por: Li, Hai-Tao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_blg2v9u1sq86c2oo8e37454od2